1. Home
  2. CDTX vs IMMR Comparison

CDTX vs IMMR Comparison

Compare CDTX & IMMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDTX
  • IMMR
  • Stock Information
  • Founded
  • CDTX 2012
  • IMMR 1993
  • Country
  • CDTX United States
  • IMMR United States
  • Employees
  • CDTX N/A
  • IMMR N/A
  • Industry
  • CDTX Biotechnology: Biological Products (No Diagnostic Substances)
  • IMMR Computer peripheral equipment
  • Sector
  • CDTX Health Care
  • IMMR Technology
  • Exchange
  • CDTX Nasdaq
  • IMMR Nasdaq
  • Market Cap
  • CDTX 259.0M
  • IMMR 229.0M
  • IPO Year
  • CDTX 2015
  • IMMR 1999
  • Fundamental
  • Price
  • CDTX $21.69
  • IMMR $7.41
  • Analyst Decision
  • CDTX Strong Buy
  • IMMR Strong Buy
  • Analyst Count
  • CDTX 8
  • IMMR 2
  • Target Price
  • CDTX $38.00
  • IMMR $12.25
  • AVG Volume (30 Days)
  • CDTX 164.0K
  • IMMR 358.9K
  • Earning Date
  • CDTX 05-08-2025
  • IMMR 05-12-2025
  • Dividend Yield
  • CDTX N/A
  • IMMR 5.13%
  • EPS Growth
  • CDTX N/A
  • IMMR 57.07
  • EPS
  • CDTX N/A
  • IMMR 2.04
  • Revenue
  • CDTX $1,275,000.00
  • IMMR $163,133,000.00
  • Revenue This Year
  • CDTX N/A
  • IMMR $988.71
  • Revenue Next Year
  • CDTX N/A
  • IMMR $109.72
  • P/E Ratio
  • CDTX N/A
  • IMMR $3.63
  • Revenue Growth
  • CDTX N/A
  • IMMR 338.21
  • 52 Week Low
  • CDTX $10.14
  • IMMR $6.47
  • 52 Week High
  • CDTX $28.42
  • IMMR $13.94
  • Technical
  • Relative Strength Index (RSI)
  • CDTX 56.70
  • IMMR 52.89
  • Support Level
  • CDTX $19.97
  • IMMR $7.08
  • Resistance Level
  • CDTX $22.80
  • IMMR $7.45
  • Average True Range (ATR)
  • CDTX 1.37
  • IMMR 0.20
  • MACD
  • CDTX 0.29
  • IMMR 0.06
  • Stochastic Oscillator
  • CDTX 74.55
  • IMMR 89.83

About CDTX Cidara Therapeutics Inc.

Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.

About IMMR Immersion Corporation

Immersion Corp is focused on the creation, design, development, and licensing of haptic technologies that allow people to use its sense of touch more fully as it involves engaging with products and experience the digital world. The company's software focuses on applications in mobile devices, wearables, consumer, and gaming devices markets. It generates revenue from royalty and license fees, and development contract and service fees. Geographically, the company generates a majority of its revenue from Japan, followed by Korea, Germany, United States of America and other countries.

Share on Social Networks: